{"schema_version":"1","generated_at":"2026-11-02T08:04:11.851Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anuradha-krishnamurthy","json_url":"https://www.findmykol.com/kol/anuradha-krishnamurthy/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anuradha-krishnamurthy","name":"Anuradha Krishnamurthy","credential":"MB, BS","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Roswell Park Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/roswell-park-comprehensive-cancer-center","city":"Buffalo","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1710333943","orcid":"0009-0004-5230-7466","openalex":"A5060102963"},"summary":"Anuradha Krishnamurthy is an Oncology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 49 publications with 843 citations (h-index 14); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":49,"cited_by_count":843,"h_index":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06968195","title":"Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma","phase":"PHASE1","status":"SUSPENDED","role":"Overall official","sponsor":"Roswell Park Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06968195","trial_url":"https://www.findmykol.com/trial/NCT06968195"},{"nct":"NCT06011772","title":"EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer","phase":"EARLY_PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Roswell Park Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06011772","trial_url":"https://www.findmykol.com/trial/NCT06011772"},{"nct":"NCT02260440","title":"A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Anuradha Krishnamurthy","source_url":"https://clinicaltrials.gov/study/NCT02260440","trial_url":"https://www.findmykol.com/trial/NCT02260440"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Intera Oncology, Inc","program_year":2024,"amount_usd":143.02,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710333943"},{"payer":"Exelixis Inc.","program_year":2024,"amount_usd":44.1,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710333943"},{"payer":"Ipsen Biopharmaceuticals, Inc","program_year":2022,"amount_usd":150.85,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710333943"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1710333943","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Upfront surgery versus neoadjuvant chemotherapy in resectable pancreatic adenocarcinoma.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16472","status":"verified"},{"title":"Histopathological Evaluation of Placental Fetal Vascular Malperfusion: A Comprehensive Review","year":2026,"journal":"International Journal of Infertility & Fetal Medicine","source_url":"https://doi.org/10.5005/jp-journals-10016-1413","status":"verified"},{"title":"Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406)","year":2025,"journal":"Cancer Chemotherapy and Pharmacology","source_url":"https://doi.org/10.1007/s00280-024-04745-6","status":"verified"},{"title":"10-year follow up of a phase 2 clinical trial of pembrolizumab (pembro) in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.4019","status":"verified"},{"title":"Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer","year":2025,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-025-63960-8","status":"verified"}],"source":"works"},"contact":{"address_1":"ELM AND CARLTON ST","city":"Buffalo","state":"NY","zip":"142630001","phone":"716-845-2300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1710333943","source":"identity"},"similar":[{"name":"Igor Puzanov","slug":"igor-puzanov","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/igor-puzanov","json_url":"https://www.findmykol.com/kol/igor-puzanov/profile.json"},{"name":"Philip McCarthy","slug":"philip-mccarthy","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/philip-mccarthy","json_url":"https://www.findmykol.com/kol/philip-mccarthy/profile.json"},{"name":"Saby George","slug":"saby-george","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/saby-george","json_url":"https://www.findmykol.com/kol/saby-george/profile.json"},{"name":"Eunice Wang","slug":"eunice-wang","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/eunice-wang","json_url":"https://www.findmykol.com/kol/eunice-wang/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-05-19","provider_certified":"2022-05-13","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}